ketamine troches
Articles tagged with “ketamine troches”
Ketamine Troche: Swallow or Spit After Dissolving?
Most ketamine troche protocols say spit after the hold. Here's why it matters for absorption and what to ask your prescribing clinician.
FDA Moves Against Illegal Ketamine Sellers in 2026
The FDA is targeting illegal ketamine sellers in 2026. Here's what this enforcement action means for patients using compounded ketamine troches.
Spravato vs Ketamine Troches: Effectiveness Compared
How does Spravato (esketamine nasal spray) compare to ketamine troches for depression? A plain-language breakdown of effectiveness, access, and key differences.
Ketamine Research: Hope for Resistant Depression Patients
New research highlights ketamine's rapid antidepressant effects in treatment-resistant depression and suicidal ideation — what troche patients need to know.
Subcutaneous Ketamine vs Troches: Patient Outcomes Compared
How do subcutaneous ketamine injections compare with troches for patient outcomes? A route-by-route guide for informed clinical conversations.
Esketamine Nasal Spray vs. Troches: What TRD Data Shows
Psychiatric Times reviews esketamine nasal spray safety for TRD and MDD — key findings and what ketamine troche patients should know.
Non-Drug Approaches Boost Ketamine Troche Outcomes
New research explores how behavioral therapy and neuroplasticity techniques can enhance ketamine troche treatment outcomes for depression.
Ketamine Troches vs Oral Capsules: Bioavailability Differences
Learn how ketamine troches and oral capsules differ in bioavailability. Compare sublingual absorption vs oral absorption for informed treatment discussions.
Ketamine Troche Shelf Life: Storage, Safety & Expiration Guide
Learn how long ketamine troches last, proper storage requirements, refrigeration needs, and safety considerations for at-home treatment.
Ketamine Troches vs Suppositories: Bioavailability Comparison
Compare bioavailability between ketamine troches and suppositories. Learn absorption differences, practical considerations, and what matters for treatment decisions.
How Long Do Ketamine Troches Last in the Refrigerator?
Learn about ketamine troche shelf life in refrigeration, proper storage conditions, and when to replace expired medication safely.
Boston Clinics Spotlight Ketamine's Mental Health Role
Boston-area clinics are spotlighting ketamine for depression and anxiety. Here's what their approach means for patients using at-home ketamine troches.
TMS vs. Ketamine: What TRD Patients Should Know
Medical Daily covers when to try ketamine or TMS for treatment-resistant depression. Here's what it means for patients weighing ketamine troches.
IV Ketamine in the News: What Troche Users Should Know
A FOX 4 Kansas City segment spotlights IV ketamine therapy. Here's what the growing media attention means for ketamine troche patients and at-home access.
Ketamine & Workers' Comp: What Alabama's Rules Mean
Alabama workers' comp cases are testing ketamine therapy coverage standards. Here's what this legal shift means for troche access and reimbursement in 2026.
Esketamine Clinic Protocols: What Troche Patients Should Know
New esketamine clinic-protocol guidance shows why sublingual ketamine troches stay a flexible, accessible alternative for many treatment-resistant patients.
NMDA Side Effects: What the Data Means for Troche Users
New research on NMDA antagonist side effects and discontinuation rates offers practical guidance for ketamine troche patients managing treatment-resistant depression.
Ketamine Dropout Rates: Why Delivery Format Changes Everything
New clinical data on NMDA antagonist side effects and dropout rates shows why ketamine troche delivery may offer a meaningful tolerability advantage.
Side Effects & Stopping Rates: What NMDA Data Means
New data on NMDA antagonist side effects and discontinuation rates has direct implications for ketamine troche patients managing treatment-resistant depression.
Ketamine Side Effects: What New Data Means for Troches
New 2026 NMDA-antagonist data on troche side effects and discontinuation rates: how ketamine troches compare on safety and tolerability vs other formats.
Insurance Gaps Push Patients to Ketamine Access Funds
Most insurers still deny ketamine coverage for depression. Learn how patient assistance programs are bridging the gap and what it means for troche access.
Esketamine vs. Troches: What TRD Patients Should Know
A new clinical review on esketamine for TRD highlights access barriers and patient preferences — here's what it means for ketamine troche therapy.
Esketamine TRD Access Gaps Open Doors for Troches
New clinician data on esketamine for TRD reveals access barriers that make compounded ketamine troches a practical frontline option for many patients.
France Approves IV Ketamine for Suicidal Crisis: What It Means
France has approved IV ketamine for acute suicidal crises. Here's what this global shift means for ketamine troche patients and at-home treatment access in the U.S.
Contact Ketamine Troche
Send corrections, provider questions, or advertising inquiries.